Stago

Stago is a long-established, privately-held global leader in the specialized diagnostics market of hemostasis and thrombosis. The company operates on an integrated business model, selling its proprietary instruments, reagents, and associated quality control and digital services directly to laboratories. With a strong international presence, a focus on continuous innovation (evidenced by its new 'sthemO' platform), and a portfolio of acquired specialty brands, Stago is well-positioned in the growing diagnostics sector for bleeding and clotting disorders.

Integrated systems for hemostasis diagnostics, including automated coagulation analyzers (STA series, sthemO), specialized reagents, thrombin generation, viscoelastic testing, flow cytometry for microvesicles, platelet aggregometry, and digital/data services for quality control and customer support.

Stago competes in the global hemostasis diagnostics market against major players like Werfen (Instrumentation Laboratory), Siemens Healthineers, Roche Diagnostics, and Sysmex. Its competitive advantage lies in its deep specialization, integrated instrument/reagent/digital ecosystem, and a portfolio of niche brands that address segments from core lab to research and point-of-care.